VENUS REMEDIES LIMITED showed weakness today. It fell by -1.17% to close at 42.1. During the last week it fell by -3.77% and saw a maximum drawdown of -4.97% before bouncing back.
VENUSREM is currently in a bearish trend. Over the last three months Buy-and-Hold has been a better strategy (returning +10.21%) for VENUSREM's investors than shorting it.
VENUSREM has been underperforming the NIFTY-50 index in recent time. It showed significant underperformance (compared to the NIFTY-50 index) from 1 Feb, 2016 to 1 Oct, 2018. Over the last 3 years and 1 month, VENUSREM underperformed the NIFTY-50 index on 60% days.
During the last three months VENUSREM delivered losses on 59% days. However, it still managed to end this period in a profit. It's best return during this period (of +19.98%) was on Friday, 16 Nov, 2018. While it's worst loss in the same period (of -9.3%) was on Thursday, 22 Nov, 2018. The longest stort-term trend during this period was 8 losing days, which started on 30 Nov, 2018 and ended on 11 Dec, 2018. This bearish trend lost -23.79% of investor capital.
During the last year VENUSREM had 3 profitable months and 9 loss making months. VENUSREM returned profits in fewer months than NIFTY-50 index. VENUSREM significantly outperformed NIFTY-50 index in Nov 2018, when it returned +35.71% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. VENUSREM had a longer winning streak of losing months than NIFTY-50 index. It went down in 5 straight months (from Feb 2018 to Jun 2018) during which period it delivered -61.46%. It is interesting to note that both VENUSREM and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.
"Once my ears were open to hearing mentions of 'Shark Tank', I was surprised by how many people in our world, even in our industry, tech and finance, loved the show.
VENUSREM is currently seeing overall fall in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant fall in VENUSREM's volatility from 22 Oct, 2018 to 14 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.
Advanced/professional short-term investors should note that VENUSREM has significant negative skewness in it's return distribution. This indicates that VENUSREM is very risky for short-term investment and can significantly underperform for long durations.
NIFTY-50 index has more chance of extreme outcomes than VENUSREM. Therefore, NIFTY-50 must receive a lower allocation than VENUSREM in your portfolio. NIFTY-50 index usually has shorter drawdown period than VENUSREM.
... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.
All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.
We want to empower investors with all the tools and analysis required by them to make a rational investment decision.If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute